Tenet Healthcare (NYSE:THC) Issues FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 20.300-21.690 for the period, compared to the consensus EPS estimate of 17.810. The company issued revenue guidance of $21.9 billion-$22.5 billion, compared to the consensus revenue estimate of $22.0 billion.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on THC shares. Robert W. Baird decreased their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Weiss Ratings lowered shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Wall Street Zen lowered Tenet Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, July 18th. KeyCorp decreased their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Seventeen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $246.47.

Tenet Healthcare Trading Up 17.1%

Shares of NYSE:THC opened at $233.10 on Friday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The firm has a market capitalization of $20.08 billion, a P/E ratio of 8.99, a P/E/G ratio of 1.65 and a beta of 1.27. The business’s 50-day moving average is $185.16 and its 200 day moving average is $197.62. Tenet Healthcare has a 1 year low of $146.60 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Friday, July 24th. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 27.17% and a net margin of 10.27%.The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.02 earnings per share. On average, research analysts predict that Tenet Healthcare will post 17.5 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.97% of the company’s stock.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet’s Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Quadrant Capital Group LLC increased its stake in Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after acquiring an additional 58 shares during the last quarter. Syon Capital LLC increased its stake in Tenet Healthcare by 5.3% during the fourth quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after purchasing an additional 63 shares during the period. Geneos Wealth Management Inc. boosted its position in Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after buying an additional 89 shares during the period. UMB Bank n.a. boosted its stake in shares of Tenet Healthcare by 9.3% in the 4th quarter. UMB Bank n.a. now owns 1,169 shares of the company’s stock valued at $232,000 after buying an additional 99 shares during the period. Finally, Johnson Investment Counsel Inc. grew its stake in shares of Tenet Healthcare by 4.8% during the fourth quarter. Johnson Investment Counsel Inc. now owns 2,445 shares of the company’s stock worth $486,000 after purchasing an additional 112 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.